Returned for evaluation was one port and catheter tubing attached.As received the catheter was trimmed to approximately 24 cm and was attached to the port.There was a small gap between the blue boot and the port body with some bio matter in this gap.Leak testing was performed with air at 40 psi through septum with distal tip of catheter clamped, no decay (.00 psi in 7 seconds) was detected.The device met all manufacturing dimensional specifications.The customer's complaint description of leak during injection could not be confirmed.No manufacturing non-conformance were observed during sample evaluation and the catheter tubing met dimensional specifications.No manufacturing related or any other defects were noted during the evaluation.A definitive root cause could be determined.The end user attaches the catheter tubing and blue boot to the port during the implantation procedure.A device history report review of the affected lots revealed no quality related issues or manufacturing deficiencies at the time of manufacture.The instructions for use, which is supplied to the user with this catalog number, contains the following statements: caution: it is extremely important to adequately flush the port after blood withdrawal.Occlusion of the catheter can occur if blood is left in the catheter for an extended period of time.Power injection should not be performed if blood aspiration is not present or the port is difficult to flush.If the implanted port is utilized, it may result in device failure or patient injury.Two-way obstruction (unable to infuse through the port system and unable to aspirate blood): causes: a fibrin tail, clot or sheath may be on or within the catheter.The non-coring (huber point) needle may not be patent or properly positioned within the port septum.Confirm that the needle is of sufficient length and, when positioned in the septum, the needle opening is not occluded by the septum.The clamp on the non-coring (huber point) needle should be open.A drug precipitate caused by incompatible drugs infused through the port may be obstructing the system.To prevent, use adequate amounts of sterile normal saline between incompatible solutions.A thrombolytic agent may be used on the order of a physician to restore patency.The procedure should be outlined by the drug manufacturer's labeling.Use facility protocol to determine which thrombolytic agent to use.The use of streptokinase has been known to cause allergic and anaphylactogenic reactions.A contrast study performed through the port may confirm fibrin sheath presence, kinking, malposition, or pinch-off syndrome.Caution: do not force solutions through the port system to clear an obstruction.A high pressure situation may cause irreversible catheter damage, leading to port system explant.Pinch-off syndrome: pinch-off syndrome signs may include difficulty in aspirating blood, resistance to flushing or infusion of medications or fluids that improves with position changes, infraclavicular pain and/or swelling with catheter flushing or infusion palpitations, sudden onset chest pain, cardiac arrhythmias, extra heart sound, chest wall swelling at the port pocket, vein insertion site, pain in shoulder or port area not associated with swelling, cough, paresthesia of arm on side of catheter withdrawal occlusion or swishing sound with catheter flushing.Warning: avoid medial catheter placement into subclavian vein through percutaneous technique.This placement could lead to catheter occlusion, damage, rupture, shearing, or fragmentation due to compression of the catheter between the first rib and clavicle.Catheter shearing has been reported when the catheter is inserted via a more medial route in the subclavian vein.1.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Complaint reference (b)(4).
|